Home › Myasthenia Gravis › Colorado › Colorado Springs
Myasthenia Gravis clinical trials in Colorado Springs, CO
3 studies for Myasthenia Gravis are looking for participants at sites in and around Colorado Springs (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
RecruitingPhase 3
- Research of the Rockies LLC, Colorado Springs
A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)
RecruitingPhase 2
- TG Therapeutics Investigational Trial Site, Colorado Springs
- TG Therapeutics Investigational Trial Site, Colorado Springs
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
RecruitingObservational study
- Clinical Trial Site, Colorado Springs
About Myasthenia Gravis
Myasthenia gravis (MG) is an autoimmune disease that weakens the muscles under your control. Find out about MG causes, symptoms, and treatment.
More about Myasthenia Gravis on MedlinePlus
Myasthenia Gravis trials in other cities
- Tampa, FL11 studies
- Houston, TX10 studies
- Durham, NC8 studies
- Columbus, OH8 studies
- Boca Raton, FL8 studies
- Milwaukee, WI7 studies
- Washington, DC6 studies
- Detroit, MI6 studies
- Miami, FL6 studies
- New York City, NY6 studies
- Philadelphia, PA6 studies
- Portland, OR6 studies
Other studies in Colorado Springs
- Crohn's Disease14 studies
- Ulcerative Colitis12 studies
- Prostate Cancer11 studies
- Non-Small Cell Lung Cancer9 studies
- Lung Cancer7 studies
- Breast Cancer7 studies
- Colon Cancer6 studies
- Colorectal Cancer6 studies
- Asthma5 studies
- Idiopathic Hypersomnia5 studies
- Head and Neck Squamous Cell Carcinoma5 studies
- Rectal Cancer4 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.